e-Profile Login and ID Quick Search
Latisse Frequently Sold Without Prescription and Often Online
Allergan’s prescription eyelash growth product, Latisse, is frequently sold without a prescription, and often over Internet Web sites that do not require prescriptions based on face-to-face physician-patient examinations, as reported in a recent New York Times article. By purchasing Latisse without a valid prescription, consumers take the risk of receiving an adulterated or counterfeit product, and they do not receive proper consultation on product use. While most patients who use the genuine Latisse product do not experience side effects, some patients have experienced redness, itchiness, or irritation. Less commonly, patients have experienced discoloration of the eyelids, and in rare cases, the eye color of some patients has permanently changed from blue or hazel to brown. Carmen A. Catizone, executive director/secretary of NABP, stressed to the Times that by designating Latisse a prescription drug, Food and Drug Administration (FDA) recognizes the need for doctor supervision due to the possibility of side effects, misuse, or inappropriate use that could cause harm. An Allergan representative emphasized that the company has a policy against online sales of Latisse, that it investigates violations of the policy, and that it will cut off supplies to doctors who violate the policy.
